Yupelri

COPD

Pharma

Theravance's COPD med Yupelri flunks head-to-head study

Theravance and Viatris’ Yupelri failed to demonstrate greater lung function improvement in adults with COPD versus Boehringer's Spiriva.

Fraiser Kansteiner Jan 5, 2024 10:14am

Woman in car for Yupelri

Viatris and Theravance emphasize one-a-day Yupelri for COPD

Jan 19, 2021 8:30am